SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ForYourEyesOnly who wrote (661)12/23/1997 7:58:00 AM
From: John McCarthy  Read Replies (1) of 887
 
THC -

A pence:

(1) Cash vs. Burn Rate. Wait till 4th Qtr. Financials.

(2) No 98 Revenues - how big eventual dilution hit?

(3) FDA Register, why 7 unevaluable.

(4) With respect to current L & L & ST testing.

Speculation on this thread:
DC will show marginal results vs. M for Solid Tumor.

Trial requires 40 bodies.

Speculation on this thread:
DC's best shot is vs. L & L.

Trial requires 80 bodies.

I expect FDA review by December 1998 - or -
cesstation (sp) of trials.

DEPO MGMT. can't cherry pick the trial population.

Too many folks up here will SCREAM if Evaluable #
different than TOTAL POPULATION #.

(5) I'm not focused on Brain testing. But the comments
out of Florida University certainly were positive.
RE:Dr. Maria

(6) DepoMorph - vaporware for now.

If I can't get past 1-4 ....

Regards,

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext